<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: DNA repair capacity (DRC) is a determinant not only of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development but also of individual response to therapy </plain></SENT>
<SENT sid="1" pm="."><plain>Previously, altered base and nucleotide excision repair (BER and NER) have been described in lymphocytes of patients with <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We, for the first time, evaluate both excision repair capacities in human colon biopsies to study their participation in colorectal <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Experimental design: Seventy pairs of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and adjacent healthy tissues were analyzed for BER- and NER-specific DRC by a comet repair assay </plain></SENT>
<SENT sid="4" pm="."><plain>Tissue pairs were further compared for expression levels of a panel of 25 BER and NER genes complemented by their promoter methylation status </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: We observed a moderate increase of NER-DRC (P = 0.019), but not of BER-DRC in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>There was a strong correlation between both tissues for <z:hpo ids='HP_0000001'>all</z:hpo> investigated parameters (P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>However, 4 NER (CSB, CCNH, <z:e sem="disease" ids="C0268135" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">XPA</z:e>, <z:e sem="disease" ids="C0268138" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">XPD</z:e>) and 4 BER (NEIL1, APEX1, OGG1, PARP1) genes showed a 1.08- to 1.28-fold change difference in expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (P &lt; 0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>Individual gene expression levels did not correlate with overall DRC, and we did not detect any aberrant methylation of the investigated genes </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Our complex analysis showed that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells are not deficient in BER and NER, but rather follow patterns characteristic for each individual and are comparable with adjacent tissue </plain></SENT>
<SENT sid="10" pm="."><plain>Alteration of excision repair pathways is not a pronounced event in colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>This study shows the feasibility of DRC evaluation in human solid tissues, representing a complex marker of multigene DNA repair processes </plain></SENT>
</text></document>